A Review of New Drug Innovation – Emerging Challenges And Mitigation Strategies
Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2014, Vol 4, Issue 1
Abstract
: The present paper reviews trends in the development and approval of new drugs. The pharmaceutical industry continues to face the problems of high costs of new drug development, FDA’s regulatory regime, and competition from generic drugs. At the same time, consumers’ expectations regarding drug efficacy and safety have continued to increase. This explains why it has become increasingly harder for drug firms to invent new molecules during the last three decades. A few of the resolutions to these problems include strategic drug development data generation, lifecycle planning for a new molecular entity and mergers and acquisitions involving biotechnology and pharmaceutical companies. Moreover, cooperation amongst FDA’s review division and industry is not at desired level to seek development of new safety and efficacy models for enhance productivity in the industry..
Authors and Affiliations
Samrat Sisodia
Keywords
Related Articles
- EP ID EP120966
- DOI -
- Views 195
- Downloads 0
[b] Assessment of Awareness and Knowledge About Package Inserts Amongst Medical Students: A Questionnaire Based Study[/b]
[b]Chromatographic Studies on the Tannins of Aerva lanata (L.) Juss. Ex Schultes[/b]
Auto-activated Thrombin Expression from Pichia pastorisSMD1168 Optimized by Plackett-Burman Design and Response Surface Methodology
Abstract: Recombinant thrombin (rThrombin) has been used topically as one component of fibrin sealant as the tissue adhesive. Recombinant prethrombin-2 is used as the precursor to generate rThrombin which is then activat...
Inadverent Hysterosalpingogram Leading To Pregnancy Loss: A Case Report
Hysterosalpingogram(HSG) is the basic investigation in an infertility workup.Here we report a case where HSG was done in a patient of infertility on day 14 of her last vaginal bleeding assuming it to be her&nb...
Asymptomatic Bacteriuria among Pregnant Women Attending Antenatal: Evaluation of Screening Test
Introduction: Asymptomatic bacteriuria in pregnancy is common with a prevalence of 2 – 10% and is similar tothat observed among non–pregnant women. It is however more likely to progress to symptomatic urinary tract...